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Abstract 
  
Background: Platycodin D (PD) is one of the important active ingredients in the root of the Platycodon grandiflorum 
(Jacq.) A. DC (PG), a traditional medicine with many pharmacological activities, especially hepatoprotective activity. 
There are some researches on the mechanism of liver protection, but it is not very clear. It is necessary to investigate it 
deeply. 
Materials and Methods: In order to evaluate the effect of PD on ethanol-induced fatty liver (EFL) and investigate the 
possible mechanism, the EFL models of rats and BRL-3A cells were set up and treated with PD of 20, 30 mg/kg body 
weight/day for four weeks, respectively. The hepatic histochemistry, liver function enzymes, oxidative stress levels, 
antioxidant enzymes and signal path enzymes were assayed. 
Results: PD significantly (P<0.01) activates signal path enzymes of Keap1, Nrf2 and small Maf either in vitro or in 
vivo, increases hepatic antioxidant enzyme expression of HO-1, SOD and GSH-Px, improves the oxidative stress 
indicated by CYP2E1, ROS, T-AOC capacity and MDA contents, reduces levels of serum ALT and AST, and then 
improves the liver injury degree by histological evaluation.  
Conclusion: PD is an effective inhibitor of EFL to ameliorate liver impairment ethanol-induced via Keap1-Nrf2-ARE 
signal path. 
 
Keywords: platycodin D; ethanol-induced fatty liver; nuclear factor erythroid 2 related factor 2; Kelch-like ECH 
associated protein 1; small Maf 
 
List of Abbreviations: PD: platycodin D, PG: Platycodon grandiflorum (Jacq.) A. DC, EFL: ethanol-induced fatty 
liver, Nrf2: Nuclear factor erythroid2 related factor 2, Keap1: Kelch-like ECH associated protein 1, ARE: antioxidant 
response element, HO-1: heme oxygenase1, SOD: superoxide dismutase, GSH-Px: glutathione peroxidase, CYP2E1: 
Cytochrome P450 2E1, T-AOC: total antioxidant capacity, MDA: methane dicarboxylic aldehyde, ROS: reactive 
oxygen species. 
 
 
Introduction 
 
Improper ethanol consumption can cause ethanol-induced fatty liver (EFL), the most common one of the liver 
impairments (Arteel, 2003). The major cause of it is the role of lipid peroxidation and oxidative stress (Vishnudutt et al., 
2008) caused by the CYP2E1-generated ROS (Butura, et al., 2009). And it has been shown that the diseases-related 
oxidative stress has a decline of Nrf2 expression (Sussan et al., 2009). Nrf2 is a member of the Cap’n’Collar 
transcription factor family, and normally bound to the Kelch-like ECH associated protein (Keap1) in cytoplasm (Tong 
et al., 2006). Disassociated from Keap1, the Nrf2 enters into nucleus and dimerizes with small Maf proteins, then 
recognizes and binds to antioxidant response element (ARE) in promoter of target genes to promote the transcriptional 
activation of antioxidative genes and cytoprotective enzymes, which forms the defense system against oxidative stress 
(Yates et al., 2006).  
Ideal pharmacological reagents that can prevent or reverse the EFL are the traditional natural medicines (Ngo et al., 
2013). So PD, extracted from Platycodon grandiflorum (Jacq.) A. DC (as shown in Figure 1) with many medical 
effects in traditional Chinese medicine system (National pharmacopoeia commission, 2015), was chosen to evaluate the 
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effect on EFL in rats and BRL-3A cell. The liver protection of PG and its extracts was reported in the literature, such as 
saponins’ hepatoprotective effects on acute ethanol-induced in mice (Khanal et al.,2009), aqueous extract’ improving 
effects on acetaminophen or carbon tetrachloride-induced liver damage in mice(Lee et al., 2001, Lee and Jeong, 2002), 
protective effects of saponins against fatty liver in chronic ethanol feeding via the activation of AMP-dependent protein 
kinase(Khanal et al.,2009), treatment with PD effectively against EFL through anti-inflammatory and anti-endotoxic 
process via TLR4-MyD88-NF-αB signal path (Wu et al., 2016). On the other hand, the saponins, oleanolic acid 
compounds from natural products can protect liver by increased expression of liver Nuclear factor erythroid2 related 
factor 2 (Nrf2) and its downstream protective enzymes (Reisman et al., 2009; Sussan et al., 2009). Therefore, in this 
article, we further studied whether the effect of PD on EFL is controlled by the other mechanism of Nrf2-related signal 
path.  
 
Materials and Methods 
Preparation of PD  
 
The PD used in this study is the oleanolic acid, a triterpenoid bidesmoside compose of an aglycone moiety, 
3-glucose and 28-O-arabinosyl-rhamnosyl-xylosyl-apiosyl (as shown in Figure 2), purity of 92.28% and relative 
molecular mass of 1225.38, a polar solvent extract obtained from the roots of PG that possessed two years’ growth time, 
collected from Lu-mountain (Zibo, China) , and identified by the expert of plant taxonomy, Professor Shoujin FAN 
from College of Life Sciences, Shandong Normal University (Jinan, China). The methods of extracting and identifying 
of PD has been published previously (Wu et al., 2012).  
 
                         
 
 
 
 
 
 
 
 
 
 
 
 
                                       Figure 1: Images of PG 
             
 
 
 
 
 
 
 
 
 
 
 
 
                                              
Figure 2: Structure of PD 
 
Animals and treatments  
 
The sixty experimental Female Sprague-Dawley rats weighing (210 ±28) g were randomly divided into five 
groups (n=12): normal control (NC) group, ethanol-induced fatty liver (EFL) group, low dose PD (PD-l) group, high 
dose PD (PD-h) group and positive medicine simvastatin (PM) group, respectively. Except NC group was given equal 
normal saline during the entire experiment, the other rats were given 40% ethanol 10 mL and fish oil (Mission Hills, 
CA 91346-9606, America) 4 mL /kg BW/day by gavage with needle tubing, respectively, for five weeks, so as to 
induce the EFL. From the sixth to the ninth week, PD-l and PD-h groups were given 20 and 30 mg/kg BW/d PD by 
gavage, and PM group was given 25 mg/kg BW/d simvastatin (Beijing shuanglu, China, H20058534), respectively. All 
experiments were indeed carried out in accordance with the guidelines of the Ethics Committee on Animal Experiments 
of Medical School of Shandong University (NO. 2010011). 
The blood sample from heart of each rat anaesthetized with intraperitoneal sodium pentobarbital was centrifuged 
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at 3000 r/min to obtain serum. The liver samples from rats sacrificed by cervical dislocation were rapidly removed, 
washed in saline, and immersed in liquid nitrogen.  
 
Cell culture and treatments 
 
The BRL-3A cells (Chinese Academy of Sciences, China) were seeded onto 96-well plates and divided into 5 
groups (n=4): group CG treated with 5% Tween 80 in PBS which was the solvent for PD, group EG treated with 200 
mmol/L ethanol, group PDl treated 0.15 mg/mL PD, group PDh treated with 0.25 mg/mL PD, and group SIM treated 
with 0.25 mg/mL simvastatin. The latter three groups co-treated with 200 mmol/L ethanol. The treatment duration was 
24 h. PD and simvastatin were added 2 h before the ethanol treatment.  
 
Biochemistry assay of hepatic function and oxidation levels 
 
The biochemical indicators of rats were measured using ALT and AST commercial test kits (Sigma, USA). 
Hepatic oxidation levels of rats were determined by T-AOC, MDA content and ROS commercial kits (Nanjing 
Jiancheng, China). 
 
Histological observation assay of liver 
 
The freezing liver tissues were processed routinely to 10 μm sections (Leica-cm3050s, Germany). The sections 
were immersed in 10% formalin for 30 min, washed with 70% ethanol, and immerged in Sudan III dye for 25 min. The 
70% ethanol was added on them to wash again. At last the sections were counterstained with hematoxylin for 5 min. 
The microphotographs were taken by microscope (CX51, Olympus, Japan) to investigate the extent of ethanol-induced 
steatosis and deposition. 
 
ELISA assay of Keap1 protein expression 
 
The liver tissue was homogenised in RIPA buffer (Shanghai Beyotime, China), centrifuged at 12 000 r/min for 10 
min at 4 °C, and the cytokines levels in the supernatant were measured by ELISA kits (BioLegend, America) and BCA 
protein assay Kits (Thermo Fisher, America).  
 
Immunohistochemical analysis of Nrf2 protein expression 
 
Antibody against Nrf2 (Wuhan Boster, China) was dropped onto the 8 μm section of liver, incubated at the 37 °C 
for 1h. The secondary antibody was added to the sections at 37°C for 20 min, and then the reagents of 
strept-avidin-biotin complex were added to the sections at 25 °C for 20 min. The target protein was stained and the 
resultant photomicrographs were taken with microscope camera (Cx51, Olympus Japan) and quantitative by software 
of Evaluation Image-Pro
+
 4.5.  
 
Immunoblot analysis of CYP2E1 protein expression 
 
The 40 μg lysed proteins of liver tissue were loaded onto a 12% sodium dodecyl sulphate-polyacrylamide gel and 
transblotted onto a polyvinylidene fluoride membrane (Bio-Rad, America). Nonspecific proteins were blocked for 2 h. 
The membranes were immunoblotted with primary antibody of CYP2E1 (1:800, Cell Signaling Technology, America) 
at 4 °C overnight, then incubated with a secondary goat anti-rabbit horseradish peroxidase-conjugated antibody 
(Zhongshan Golden bridge, China) for 2 h, and finally detected by chemiluminescent substrate kits (Alpha Diagnostic, 
America), following by autoradiographic and densitometric analysis.  
 
Real-time PCR analysis of Nrf2-related genes expression 
 
Total RNAs samples obtained from each liver and BRL-3A cells were isolated by TRIZOL reagents (Invitrogen, 
America) and the cDNA synthesis were done using cDNA synthesis kits (Bio-Rad, America). LightCyler Probe Design 
software 2.0 was used to design primers for the target genes of the Nrf2, Keap1, small Maf, HO-1, SOD and GSH-Px, 
and reference gene GAPDH. Applied Biosystems 7900HT Fast Real-Time PCR System (ABI, America), 
TOYOBO-Realtime PCR Mater Mix (SYBR Green, Toyobo, Japan), standard procedures, and SDS software 2.3 were 
used to assess the mRNAs expression. The Ct values were calculated by the computer automatically, and the data were 
calculated and counted with 2 
-△△Ct methods.  
 
Statistical analysis   
 
All date were presented as (mean ± SD). Differences among groups were assessed using unpaired student’s t test 
and one-way ANOVA. The significantly different at 
**
P < 0.01 and 
*
P < 0.05 compared with AFL or EG groups, 
#
P < 
0.01 compared with NC or CG groups.  
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Results 
Changes of ethanol-induced liver injury and oxidative stress 
 
The histopathological studies showed that EFL group, compared to the NC’s, were induced degeneration in 
hepatocytes and hepatic cords, and focal necrosis. The severe hepatic lesions induced by ethanol plus fish oil were 
reduced remarkably (P<0.01) by the administration of PD and simvastatin, and this was in good agreement with the 
results of ALT and AST (as shown in Figure 3) .The levels of serum ALT and AST in EFL rats were significantly 
increased by 232.39%, 323.59%, respectively, compare to the NC group (P <0.01, as shown in Figure 4). The oxidative 
stress reflected by T-AOC, MDA, CYP2E1 and ROS levels were significantly (P <0.01) higher by 73.17%, and lower 
by 180.66%, 319.80% and 182.37% , respectively, in EFL rats than those in normal control group. Similarly, The HO-1, 
SOD and GSH-Px levels are lower by 68.82%, 61.35%, 81.65% , respectively, in EFL rats than them in NC rats (P 
<0.01, as shown in Figure 5).  
The marked improving effects (P <0.01) on liver injury, biochemical criterion, oxidative stress and oxidase 
activity appeared in PD and simvastatin treatment rats compared with EFL group’s. 
 
 
 
Figure 3: Images of histological injury on liver of rats 
 
5 images were randomly selected in each group and were randomly selected 3 horizons at high magnification（×400）
to view. 
 
 
 
 
 
 
 
 
Figure 4: Changes of liver injury in rats. 
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Figure 5: Changes of oxidative stress on liver of rats 
 
Changes of Nrf2-related signal path enzymes 
 
The proteins expression of Keap1 and Nrf2, and the mRNA expression of small Maf were decline dramatically 
(P< 0.01) by 69.78%, 63.04% and 55.88% respectively in EFL rats compared to normal control group’s (as shown in 
figure 6). Ethanol treatment to BRL-3A cells decreased the three mRNA expression obviously (P< 0.01) by 60.12%, 
69.89% and 58.36%, respectively, in EG model group cells compared with CG group’s (as shown in figure 7). Either in 
vitro or in vivo, the reductions were significantly (P< 0.01) increased by PD and simvastatin treatments.  
  
 
Figure 6. Changes of Nrf2-related signal path enzymes of rats 
 
 
Figure 7: Changes of Nrf2-related signal path enzymes of BRL-3A cells 
 
 
Discussion 
 
Experimental model of EFL was set up successfully by gavage of ethanol plus fish oil for five weeks. In our 
published articles (Wu et al, 2016), except the histological observation, ALT levels and AST levels assay, the other 
biochemical parameters such as serum total bilirubin and endotoxin, and liver TG assays confirmed that. Our results 
showed that obvious hepatic injury was observed in experimental rats and the model could mimic key aspects of 
alcoholic liver disease of human’s.  
PD is one of the saponins, and has a property to lyse blood cells, so we have adopted oral feeding way for rats 
instead of intravenous one. The doses of experimental verification of 20 and 30 mg/kg BW/d PD to rats were not seen 
the cases of drug toxicity during the treatment for 6 to 9 weeks. Simultaneously, the doses of 0.15 and 0.25 mg/mL PD 
and 200 mmol/L ethanol, determined by LDH efflux and mitochondrial respiration assays, were used to BRL-3A cells 
and not seen the drug toxicity. Simvastatin can improve the liver function and has protective effect against oxidative 
stress in damage liver via inducted Keap1-Nrf2 signal path (Habeos et al., 2008). In our study, the simvastatin was 
selected to find out the mechanism of PD on EFL. 
It is show that the saponins, the aqueous extract and the PD from PG have hepatoprotective effects, and their 
mechanisms are via the activation of AMP-dependent protein kinase (Khanal et al.,2009) or TLR4-MyD88-NF-αB 
signal path (Wu et al., 2016). In our study, the PD is selected to learn the other possible mechanism of PD protection to 
liver injury. 
The oxidative stress plays a role in the pathogenesis of ethanol-induced liver injury (Arteel, 2003), because of 
potentially toxic metabolic and biochemical processes of ethanol metabolism, including induction of CYP2E1 (Beier 
and Mcclain, 2010). CYP2E1 contributes to ethanol-induced oxidative stress and EFL in mice associating with 
increased generation of ROS (Lu et al., 2010; Gilmore et al., 2003). In our study, PD treatment decreased the levels of 
oxidative stress by decrease the levels of MDA, CYP2E1 and ROS in rats. 
The body in response to the active oxygen damage has formed a complex oxidative stress response system, and 
the coordination response is regulated by ARE that is one of these protective genes in upstream regulation region (Itoh 
et al., 2003). Nrf2 is an activator of ARE, as a critical factor to regulate intracellular expression of many antioxidants, 
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has play a role in keeping the balance between cellular oxidant and antioxidant. Anti-oxidation process of Nrf2 has 
closely related with various type of cellular factors that plays multiple protection role in the process (Stewart et al., 
2003). Keapl-Nrf2-ARE, as an effective antioxidant regulation pathway, has played an important role for the defense, 
and reduced the oxidative stress of the human body (Rubiolo et al., 2008). When Keapl is under the stimulation of 
oxidation, its cysteine residues are oxidized, which result in the uncoupling of Nrf2 and Keapl, thereby to activate the 
phase detoxifying Ⅱ enzyme gene in downstream elements of antioxidant response sequence to generate the gene 
transcription of antioxidant enzymes, such as HO-l, SOD and GSH-Px (Cai et al., 2005).
 
Our data demonstrated that PD 
treatment inhibited the oxidative stress in ethanol-induced rats and BRL-3A cells, suggesting that the protective effect 
of the PD is via the activation of Keap1-Nrf2-ARE pathway.  
 
Conclusions  
 
The PD significantly activates signal path enzymes of Keap1, Nrf2 and small Maf either in vitro or in vivo, 
increases hepatic antioxidant enzyme expression, improves the oxidative stress, and then improves the extent of liver 
damage. The PD is proved to be an effective inhibitor of the EFL and the possible mechanism is that the PD treatment 
activates Keap1-Nrf2-ARE signal path and then enhances the body's antioxidant capacity. 
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